We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (ALADIN2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01377246
Recruitment Status : Completed
First Posted : June 21, 2011
Last Update Posted : January 10, 2018
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 18, 2017
  Study Completion Date : October 18, 2017